SCHEMBL4440669

SCHEMBL4440669

CC(=O)Oc1c(Br)cccc1C1CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.39
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 3/20 0.38
HSD17B10 Q99714 3/20 0.38
MAPK1 P28482 1/20 0.38
HPGD P15428 1/20 0.38
DRD2 P14416 1/20 0.36
DRD1 P21728 1/20 0.36
POLB P06746 2/20 0.34
CYP3A4 P08684 1/20 0.34
LMNA P02545 1/20 0.34
BACE1 P56817 1/20 0.34
GAA P10253 3/20 0.34
MAPT P10636 3/20 0.34
KMT2A Q03164 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
MEN1 O00255 1/20 0.34
MCL1 Q07820 1/20 0.34
HIF1A Q16665 1/20 0.34
HTT P42858 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4441546 0.82 KDM4E (0.54) NOTUMALDH1A1KDM4EHSD17B10MAPK1
SCHEMBL4442468 0.81 HTR1A (0.44) NOTUMALDH1A1KDM4EHSD17B10MAPK1
SCHEMBL4439192 0.81 NOTUM (0.39) NOTUMALDH1A1KDM4EHSD17B10MAPK1
SCHEMBL9646427 0.80 KDM4E (0.48) ALDH1A1KDM4EHSD17B10MAPK1HPGD
SCHEMBL28096543 0.75 LMNA (0.46) ALDH1A1KDM4EHSD17B10POLBCYP3A4
SCHEMBL28440932 0.73 KDM4E (0.42) ALDH1A1KDM4EHSD17B10MAPK1HPGD
SCHEMBL27650218 0.71 GABRA1 (0.45) ALDH1A1KDM4EHSD17B10MAPK1HPGD
SCHEMBL2154380 0.71 KDM4E (0.67) ALDH1A1KDM4EHSD17B10MAPK1HPGD
SCHEMBL28211717 0.71 SLC6A3 (0.36) NOTUMALDH1A1KDM4EHSD17B10MAPK1
SCHEMBL24849173 0.70 PTGDR2 (0.36) NOTUMHSD17B10KMT2AL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101151234-B Process for producing cyclopropylphenol derivative SANKYO AGRO CO LTD 2011-06-15 CN disclosed
US-7629494-B2 Process for producing cyclopropylphenol derivative MITSUI CHEMICALS AGRO, INC. (JP) 2009-12-08 US disclosed
US-20090054681-A1 Production Process of cyclopropylphenol derivatives SANKYO AGRO COMPANY, LIMITED (JP) 2009-02-26 US disclosed
CN-101151234-A Process for producing cyclopropylphenol derivative SANKYO AGRO CO LTD (JP) 2008-03-26 CN disclosed
EP-1880987-A1 PROCESS FOR PRODUCING CYCLOPROPYLPHENOL DERIVATIVE Sankyo Agro Company, Limited (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054681-A1 Production Process of cyclopropylphenol derivatives CBR3, CYP4X1, CYP4A11 NOTUM 3077/4885ALDH1A1 2052/4885KDM4E 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.